The purpose of this study is to improve understanding of neurological conditions. Patients
participating in this study will continue receiving medical care, routine laboratory tests,
and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care
physician. Doctors at the NIH plan to follow these patients and offer advice and assistance
to their primary care physicians.
The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics
Branch (ETB) patients not currently entered on another research protocol. No
investigational treatments will be administered on this protocol, and the NIH physicians
will be playing largely a consultative role to the patient's primary physician.
Patients may be included on this protocol if they have an identifiable neurological
disorder or represent a diagnostic puzzle. These disorders would include patients with
Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive
supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and
Patients 18-90 years of age, inclusive, are eligible.